Industry news that matters to you.  Learn more

Archives for December 2011

Sony DADC and Axela to Develop Smart Consumables for Real Time Multiplex Immunoassays

The dotLab mX System uniquely combines automated flow processing with diffractive optics to enable real time detection of binding events and full characterization of biomarkers through sequential probing. This provides significant analytical advantages for multiplex assay development and routine analysis in clinical research and diagnostics. The resultant dynamic range and panel flexibility is unachievable with any other commercially available product.

Meta-Analysis Confirms Link Between Epigenetic Changes and Prostate Cancer

The discovery of effective biomarkers in cancer will have a significant impact on disease management. With the role of the blood-based prostate cancer biomarker PSA (prostate specific antigen) surrounded by controversy, new and more effective biomarkers of this leading cause of death in men are urgently needed. Epigenetic changes are closely linked to cancer and hold promise for prostate cancer diagnosis and management, the authors of a meta-analysis, published online in the leading urology journal, The Prostate, have concluded.

Lineagen and Fast Forward Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis

Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, and Fast Forward, LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, today announced an alliance to fund the clinical development and validation of a blood-based assay for multiple sclerosis (MS). The goal of the program is to develop a test that can aid clinicians in diagnosing MS, distinguishing it from other neurological disorders, and providing the prognostic information needed to help guide treatment decisions and response to therapies.

Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-Promotion Agreement for Fully Automated RNA In Situ Hybridization Assay Systems

Ventana Medical Systems Inc., a member of the Roche Group, and Advanced Cell Diagnostics Inc. (ACD), announced today they have entered a worldwide co-promotion agreement for the first commercially available, fully automated RNA in situ hybridization (ISH) assay system capable of robust detection and visualization of virtually any expressed gene in routine clinical specimens at single-molecule sensitivity.

The Bill & Melinda Gates Foundation to Fund Biomarkers of Gut Function for Global Health

The Bill & Melinda Gates Foundation is currently seeking letters of inquiry for the grant program Biomarkers of Gastrointestinal (Gut) Function and Health. Letters of intent are due by January 11th, 2012 at 10:00 a.m. PST. The grant program is part of a new biomarker grand challenge under the Grand Challenges in Global Health, a suite of grant programs intended to help overcome bottlenecks that prevent the creation of new and better health solutions for the developing world.